US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapeutics

29.00

-0.5800-1.96%

Post-market: 29.000.00000.00%19:54 EDT

Volume:156.51K

Turnover:4.55M

Market Cap:816.24M

PE:-16.39

High:29.52

Open:28.80

Low:28.57

Close:29.58

Loading ...

Overview Company News Filings

Keros Therapeutics: Strategic Initiatives and Capital Return Signal Potential Upside

Keros Therapeutics downgraded to Neutral from Buy at BofA

Allergy Therapeutics and EAACI Honor Early Career Researcher

Cynata Therapeutics Issues New Unquoted Equity Securities

Chimeric Therapeutics Secures $2.5M Advance to Boost Clinical Trials

Ocumension Therapeutics Gains Approval for Phase III Trial of Presbyopia Treatment in China

Abbisko Therapeutics’ Pimicotinib NDA Accepted by China NMPA for TGCT Treatment

Citi Sticks to Its Buy Rating for LENZ Therapeutics (LENZ)

Pliant Therapeutics Approves Key Proposals at Annual Meeting

Odyssey Therapeutics Withdraws IPO

Eterna Therapeutics Completes $6M Private Placement

Marker Therapeutics Concludes Annual Stockholders Meeting

Coya Therapeutics Price Target Maintained With a $18.00/Share by HC Wainwright & Co.

Defence Therapeutics Secures USPTO Patent Allowance for Advanced ADC Technology

Wedbush Cuts Price Target on Vera Therapeutics to $23 From $32, Keeps Neutral Rating

MT Newswires Live

Akari Therapeutics price target raised to $7 from $4 at Alliance Global

Keros Therapeutics to return $375M in excess capital to stockholders

Tvardi Therapeutics Updates Corporate Presentation on Therapies

Knight Therapeutics Secures Strategic Licensing Agreement with Sumitomo Pharma America, Boosting Market Potential and Investment Appeal

Crispr Therapeutics AG: Stock Soars Amid Bullish Trends

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LENZ/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LENZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":29,"timestamp":1749844800000,"preClose":29.58,"halted":0,"volume":156505,"hourTrading":{"tag":"盘后","latestPrice":29,"preClose":29,"latestTime":"19:54 EDT","volume":608,"amount":17570.81,"timestamp":1749858862399},"delay":0,"floatShares":11653723,"shares":28146154,"eps":-1.769251,"marketStatus":"Market Closed","change":-0.58,"latestTime":"06-13 16:00:00 EDT","open":28.8,"high":29.52,"low":28.565,"amount":4554492.6963,"amplitude":0.032285,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.769251,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750060800000},"marketStatusCode":7,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":29.58,"preHourTrading":{"tag":"盘前","latestPrice":28.84,"preClose":29.58,"latestTime":"09:29 EDT","volume":77,"amount":2235.719948,"timestamp":1749821370092},"postHourTrading":{"tag":"盘后","latestPrice":29,"preClose":29,"latestTime":"19:54 EDT","volume":608,"amount":17570.81,"timestamp":1749858862399},"volumeRatio":0.2990981094374136,"impliedVol":0.5592,"impliedVolPercentile":0.5435},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","floatShares":11653723,"roa":"-17.75%","roe":"-24.47%","lyrEps":-2.338654,"volumeRatio":0.2990981094374136,"shares":28146154,"dividePrice":0,"high":29.52,"amplitude":0.032285,"preClose":29.58,"low":28.565,"week52Low":16.28,"pbRate":"4.25","week52High":38.93,"institutionHeld":0,"latestPrice":29,"eps":-1.769251,"divideRate":0,"volume":156505,"delay":0,"ttmEps":-1.769251,"open":28.8,"prevYearClose":28.87,"prevWeekClose":31.96,"prevMonthClose":29.2,"prevQuarterClose":25.71,"fiveDayClose":31.96,"twentyDayClose":27.34,"sixtyDayClose":25.52},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LENZ\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2542639749","title":"Keros Therapeutics: Strategic Initiatives and Capital Return Signal Potential Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2542639749","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542639749?lang=en_us&edition=fundamental","pubTime":"2025-06-10 17:25","pubTimestamp":1749547543,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Tiago Fauth from Wells Fargo maintained a Buy rating on Keros Therapeutics (KROS – Research Report), with a price t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/keros-therapeutics-strategic-initiatives-and-capital-return-signal-potential-upside-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/keros-therapeutics-strategic-initiatives-and-capital-return-signal-potential-upside-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128525689.USD","LU0251131958.USD","LU0742534661.SGD","LU0477156953.USD","LU0072461881.USD","LU0106831901.USD","IE00B19Z3B42.SGD","KROS","LU0787776722.HKD","LU0149725797.USD","BK4585","LU2361045086.USD","LU0980610538.SGD","LU0211327993.USD","LENZ","LU0320765489.SGD","LU0128525929.USD","LU0683600562.USD","LU0256863811.USD","BK4139","LU1814569148.SGD","LU2361044865.SGD","LU0130102774.USD","LU1267930490.SGD","LU1267930573.SGD","LU0154236417.USD","LU1363072403.SGD","BK4588","LU0048573561.USD","LU0417517546.SGD","LU0211328371.USD","LU1035773651.USD","LU0708994859.HKD","LU0029864427.USD","LU2461242641.AUD","LU0162691827.USD","LU0310800379.SGD","LU0314106906.USD","LU0052756011.USD","BK4559","LU1267930227.SGD","IE0002270589.USD","BK4207","LU2236285917.USD","LU1280957306.USD","LU1506573853.SGD","BK4007","LU0640476718.USD","LU0208291251.USD","LU0310800965.SGD"],"gpt_icon":0},{"id":"2542452391","title":"Keros Therapeutics downgraded to Neutral from Buy at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2542452391","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542452391?lang=en_us&edition=fundamental","pubTime":"2025-06-10 16:45","pubTimestamp":1749545110,"startTime":"0","endTime":"0","summary":"BofA analyst Jason Zemansky downgraded Keros Therapeutics (KROS) to Neutral from Buy with a price target of $18, down from $32. The company announc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/keros-therapeutics-downgraded-to-neutral-from-buy-at-bofa-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/keros-therapeutics-downgraded-to-neutral-from-buy-at-bofa-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2542622563","title":"Allergy Therapeutics and EAACI Honor Early Career Researcher","url":"https://stock-news.laohu8.com/highlight/detail?id=2542622563","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542622563?lang=en_us&edition=fundamental","pubTime":"2025-06-10 14:21","pubTimestamp":1749536498,"startTime":"0","endTime":"0","summary":"Allergy Therapeutics ( ($GB:AGY) ) has provided an update. Allergy Therapeutics, in collaboration with the European Academy of Allergy and Clinical...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/allergy-therapeutics-and-eaaci-honor-early-career-researcher?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/allergy-therapeutics-and-eaaci-honor-early-career-researcher?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2542364040","title":"Cynata Therapeutics Issues New Unquoted Equity Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2542364040","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542364040?lang=en_us&edition=fundamental","pubTime":"2025-06-10 14:03","pubTimestamp":1749535394,"startTime":"0","endTime":"0","summary":"An update from Cynata Therapeutics Limited ( ($AU:CYP) ) is now available. Cynata Therapeutics Limited announced the issuance of unquoted equity se...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cynata-therapeutics-issues-new-unquoted-equity-securities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cynata-therapeutics-issues-new-unquoted-equity-securities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4215","LENZ","BK4585","BK4539","EQR","BK4139","BK4007"],"gpt_icon":0},{"id":"2542036919","title":"Chimeric Therapeutics Secures $2.5M Advance to Boost Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2542036919","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542036919?lang=en_us&edition=fundamental","pubTime":"2025-06-10 12:57","pubTimestamp":1749531459,"startTime":"0","endTime":"0","summary":"Chimeric Therapeutics Ltd. ( ($AU:CHM) ) has shared an announcement. Chimeric Therapeutics has secured a $2.5 million advance from Endpoints Capita...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-secures-2-5m-advance-to-boost-clinical-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-secures-2-5m-advance-to-boost-clinical-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2542336600","title":"Ocumension Therapeutics Gains Approval for Phase III Trial of Presbyopia Treatment in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2542336600","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542336600?lang=en_us&edition=fundamental","pubTime":"2025-06-10 12:38","pubTimestamp":1749530328,"startTime":"0","endTime":"0","summary":"The latest update is out from Ocumension Therapeutics ( ($HK:1477) ). Ocumension Therapeutics has received authorization to initiate a phase III cl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ocumension-therapeutics-gains-approval-for-phase-iii-trial-of-presbyopia-treatment-in-china?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ocumension-therapeutics-gains-approval-for-phase-iii-trial-of-presbyopia-treatment-in-china?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4134","BK4139","BK4007","III","BK4539","LENZ"],"gpt_icon":0},{"id":"2542366905","title":"Abbisko Therapeutics’ Pimicotinib NDA Accepted by China NMPA for TGCT Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2542366905","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542366905?lang=en_us&edition=fundamental","pubTime":"2025-06-10 12:09","pubTimestamp":1749528561,"startTime":"0","endTime":"0","summary":"Abbisko Cayman Limited ( ($HK:2256) ) has provided an update. Abbisko Cayman Limited announced that its subsidiary, Abbisko Therapeutics, has recei...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbisko-therapeutics-pimicotinib-nda-accepted-by-china-nmpa-for-tgct-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbisko-therapeutics-pimicotinib-nda-accepted-by-china-nmpa-for-tgct-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2542356961","title":"Citi Sticks to Its Buy Rating for LENZ Therapeutics (LENZ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2542356961","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542356961?lang=en_us&edition=fundamental","pubTime":"2025-06-10 07:35","pubTimestamp":1749512108,"startTime":"0","endTime":"0","summary":"In a report released today, Yigal Nochomovitz from Citi maintained a Buy rating on LENZ Therapeutics (LENZ – Research Report), with a price target ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-sticks-to-its-buy-rating-for-lenz-therapeutics-lenz-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-sticks-to-its-buy-rating-for-lenz-therapeutics-lenz-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2542538693","title":"Pliant Therapeutics Approves Key Proposals at Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2542538693","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542538693?lang=en_us&edition=fundamental","pubTime":"2025-06-10 05:48","pubTimestamp":1749505720,"startTime":"0","endTime":"0","summary":"Pliant Therapeutics ( ($PLRX) ) has issued an announcement. On April 9, 2025, Pliant Therapeutics held its Annual Meeting where stockholders voted ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pliant-therapeutics-approves-key-proposals-at-annual-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pliant-therapeutics-approves-key-proposals-at-annual-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","BK4539","LENZ","PLRX"],"gpt_icon":0},{"id":"2542533358","title":"Odyssey Therapeutics Withdraws IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2542533358","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542533358?lang=en_us&edition=fundamental","pubTime":"2025-06-10 05:16","pubTimestamp":1749503760,"startTime":"0","endTime":"0","summary":"Odyssey Therapeutics has withdrawn the initial public offering it filed for in January.The Boston-based biopharmaceutical company on Monday asked the Securities and Exchange Commission to retract the filing, which did not disclose an expected share price or the number of shares it planned to sell.Odyssey said it had determined that it was not in its best interests to of the company to conduct an offering at this time.The company had planned to list shares on the Nasdaq under the ticker ODTX.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2542501358","title":"Eterna Therapeutics Completes $6M Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2542501358","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542501358?lang=en_us&edition=fundamental","pubTime":"2025-06-10 05:10","pubTimestamp":1749503456,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Eterna Therapeutics ( ($ERNA) ). Ernexa Therapeutics Inc. completed the second closing of its private placement...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eterna-therapeutics-completes-6m-private-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eterna-therapeutics-completes-6m-private-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2542433091","title":"Marker Therapeutics Concludes Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2542433091","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542433091?lang=en_us&edition=fundamental","pubTime":"2025-06-10 04:28","pubTimestamp":1749500928,"startTime":"0","endTime":"0","summary":"Marker Therapeutics ( ($MRKR) ) just unveiled an update. On June 6, 2025, Marker Therapeutics held its Annual Meeting of Stockholders, where three ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/marker-therapeutics-concludes-annual-stockholders-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/marker-therapeutics-concludes-annual-stockholders-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","LENZ","BK4007"],"gpt_icon":0},{"id":"2542384006","title":"Coya Therapeutics Price Target Maintained With a $18.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2542384006","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542384006?lang=en_us&edition=fundamental","pubTime":"2025-06-09 20:34","pubTimestamp":1749472440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/COYA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 09, 2025 08:34 ET (12:34 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","COYA"],"gpt_icon":0},{"id":"2542384390","title":"Defence Therapeutics Secures USPTO Patent Allowance for Advanced ADC Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2542384390","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542384390?lang=en_us&edition=fundamental","pubTime":"2025-06-09 19:55","pubTimestamp":1749470137,"startTime":"0","endTime":"0","summary":"Defence Therapeutics ( ($TSE:DTC) ) has issued an announcement. Defence Therapeutics has received a Notice of Allowance from the USPTO for its pate...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/defence-therapeutics-secures-uspto-patent-allowance-for-advanced-adc-technology?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/defence-therapeutics-secures-uspto-patent-allowance-for-advanced-adc-technology?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4190","AEIS","ADC","DTC","IE0031619046.USD","BK4157","IE00B66KJ199.SGD","BK4231","LENZ","IE00B7SZL793.SGD","BK4080","BK4007","BK4539","IE00B19Z4B17.USD"],"gpt_icon":0},{"id":"2542389990","title":"Wedbush Cuts Price Target on Vera Therapeutics to $23 From $32, Keeps Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2542389990","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542389990?lang=en_us&edition=fundamental","pubTime":"2025-06-09 19:20","pubTimestamp":1749468043,"startTime":"0","endTime":"0","summary":"Vera Therapeutics (VERA) has an average rating of buy and mean price target of $64.86, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VERA","LENZ"],"gpt_icon":0},{"id":"2542338910","title":"Akari Therapeutics price target raised to $7 from $4 at Alliance Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2542338910","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542338910?lang=en_us&edition=fundamental","pubTime":"2025-06-09 19:11","pubTimestamp":1749467480,"startTime":"0","endTime":"0","summary":"Alliance Global Partners analyst James Molloy raised the firm’s price target on Akari Therapeutics (AKTX) to $7 from $4 and keeps a Buy rating on t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/akari-therapeutics-price-target-raised-to-7-from-4-at-alliance-global-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/akari-therapeutics-price-target-raised-to-7-from-4-at-alliance-global-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2542638609","title":"Keros Therapeutics to return $375M in excess capital to stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2542638609","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542638609?lang=en_us&edition=fundamental","pubTime":"2025-06-09 19:00","pubTimestamp":1749466832,"startTime":"0","endTime":"0","summary":"Keros Therapeutics (KROS) announced that the Company has concluded its previously announced review process to evaluate strategic alternatives to ma...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/keros-therapeutics-to-return-375m-in-excess-capital-to-stockholders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/keros-therapeutics-to-return-375m-in-excess-capital-to-stockholders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","LENZ","KROS","BK4007"],"gpt_icon":0},{"id":"2542386531","title":"Tvardi Therapeutics Updates Corporate Presentation on Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2542386531","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542386531?lang=en_us&edition=fundamental","pubTime":"2025-06-09 18:30","pubTimestamp":1749465024,"startTime":"0","endTime":"0","summary":"Tvardi Therapeutics ( ($TVRD) ) has issued an announcement. On June 6, 2025, Tvardi Therapeutics updated its corporate presentation, highlighting i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tvardi-therapeutics-updates-corporate-presentation-on-therapies?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tvardi-therapeutics-updates-corporate-presentation-on-therapies?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"2541842525","title":"Knight Therapeutics Secures Strategic Licensing Agreement with Sumitomo Pharma America, Boosting Market Potential and Investment Appeal","url":"https://stock-news.laohu8.com/highlight/detail?id=2541842525","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541842525?lang=en_us&edition=fundamental","pubTime":"2025-06-08 14:35","pubTimestamp":1749364516,"startTime":"0","endTime":"0","summary":"Bloom Burton analyst David Martin PhD has maintained their bullish stance on KHTRF stock, giving a Buy rating on June 5. David Martin PhD has given...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/knight-therapeutics-secures-strategic-licensing-agreement-with-sumitomo-pharma-america-boosting-market-potential-and-investment-appeal-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/knight-therapeutics-secures-strategic-licensing-agreement-with-sumitomo-pharma-america-boosting-market-potential-and-investment-appeal-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LENZ","BK4539","BK4139"],"gpt_icon":0},{"id":"2541817597","title":"Crispr Therapeutics AG: Stock Soars Amid Bullish Trends","url":"https://stock-news.laohu8.com/highlight/detail?id=2541817597","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541817597?lang=en_us&edition=fundamental","pubTime":"2025-06-07 22:01","pubTimestamp":1749304889,"startTime":"0","endTime":"0","summary":"Crispr Therapeutics AG ( ($CRSP) ) has risen by 13.29%. Read on to learn why. Crispr Therapeutics AG has seen a notable increase in its stock price...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/crispr-therapeutics-ag-stock-soars-amid-bullish-trends?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/crispr-therapeutics-ag-stock-soars-amid-bullish-trends?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LU1861559042.SGD","BK4556","BK4588","BK4611","BK4007","BK4139","CRSP","LU1861558580.USD","BK4210","LENZ","BK4585","AG"],"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":5,"totalSize":205,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LENZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-08","symbol":"LENZ","fiscalQuarterEnding":"2024/03","expectedEps":-0.84,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-3.53},{"market":"US","date":"2024-03-22","symbol":"LENZ","defaultRemindTime":1711114200000,"type":"split","dateTimestamp":1711080000000,"forFactor":7,"toFactor":1,"ratio":7},{"date":"2024-03-22","symbol":"LENZ","amount":1.03,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-03-18","name":"Therapeutics","recordDate":"2024-03-21","payableDate":"2024-03-18","currency":"USD","dateTimestamp":1711080000000,"payDate":"2024-03-21"},{"market":"US","date":"2021-08-12","symbol":"LENZ","fiscalQuarterEnding":"2021/06","expectedEps":-1.11,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-3.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LENZ\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-22","recordDate":"2024-03-18","paymentDate":"2024-03-21","value":1.03,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LENZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":8,"updateTime":1742270400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LENZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LENZ","date":"2025-06-13","current":-17.439532,"percent":0.017422,"low":-18.842712,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"high":-5.069183,"avg":-10.841843,"sd":3.694257,"marketCap":832563235},"quantilePoints":[{"date":"2024-03-28","current":-7.959158,"twenty":-7.219077,"median":-6.108955,"eighty":-6.016992,"marketCap":556886354},{"date":"2024-04-05","current":-7.492045,"twenty":-7.873034,"median":-7.667213,"eighty":-6.662191,"marketCap":524203432},{"date":"2024-04-12","current":-7.929963,"twenty":-7.855517,"median":-7.667213,"eighty":-7.432197,"marketCap":554843672},{"date":"2024-04-19","current":-6.382653,"twenty":-7.855517,"median":-7.488396,"eighty":-6.783348,"marketCap":446581492},{"date":"2024-04-26","current":-5.638193,"twenty":-7.716113,"median":-7.451903,"eighty":-5.889996,"marketCap":394493084},{"date":"2024-05-03","current":-5.988527,"twenty":-7.671592,"median":-6.864363,"eighty":-5.803142,"marketCap":419005276},{"date":"2024-05-10","current":-5.317808,"twenty":-7.667213,"median":-6.108955,"eighty":-5.803142,"marketCap":393230653},{"date":"2024-05-17","current":-5.708011,"twenty":-7.597146,"median":-6.0013,"eighty":-5.749862,"marketCap":422084590},{"date":"2024-05-24","current":-5.428308,"twenty":-7.489126,"median":-6.006774,"eighty":-5.719496,"marketCap":401401679},{"date":"2024-05-31","current":-5.355793,"twenty":-7.479638,"median":-5.988527,"eighty":-5.522773,"marketCap":396039443},{"date":"2024-06-07","current":-5.193496,"twenty":-7.457742,"median":-5.904593,"eighty":-5.428999,"marketCap":384038248},{"date":"2024-06-14","current":-6.433167,"twenty":-7.451903,"median":-5.930138,"eighty":-5.428308,"marketCap":475706952},{"date":"2024-06-21","current":-6.236339,"twenty":-7.425628,"median":-5.992177,"eighty":-5.43107,"marketCap":461152311},{"date":"2024-06-28","current":-6.150011,"twenty":-7.389135,"median":-6.0013,"eighty":-5.439358,"marketCap":454768696},{"date":"2024-07-05","current":-6.098214,"twenty":-7.269437,"median":-6.014073,"eighty":-5.469746,"marketCap":450938528},{"date":"2024-07-12","current":-6.771573,"twenty":-6.771573,"median":-6.098214,"eighty":-5.493918,"marketCap":500730721},{"date":"2024-07-15","current":-7.261916,"twenty":-7.163847,"median":-6.103393,"eighty":-5.509112,"marketCap":536989651},{"date":"2024-08-02","current":-8.498134,"twenty":-7.266429,"median":-6.108573,"eighty":-5.524305,"marketCap":628403011},{"date":"2024-08-09","current":-8.328931,"twenty":-7.474529,"median":-6.146558,"eighty":-5.597209,"marketCap":615891126},{"date":"2024-08-16","current":-8.944708,"twenty":-7.671592,"median":-6.236339,"eighty":-5.641258,"marketCap":621424629},{"date":"2024-08-23","current":-8.79431,"twenty":-7.94748,"median":-6.352018,"eighty":-5.670717,"marketCap":610975896},{"date":"2024-08-30","current":-8.746816,"twenty":-8.006409,"median":-6.382653,"eighty":-5.719496,"marketCap":607676296},{"date":"2024-09-06","current":-9.451311,"twenty":-8.199004,"median":-6.419354,"eighty":-5.743293,"marketCap":656620360},{"date":"2024-09-13","current":-8.17293,"twenty":-8.352945,"median":-6.434893,"eighty":-5.773217,"marketCap":567806132},{"date":"2024-09-20","current":-8.7389,"twenty":-8.507104,"median":-6.459289,"eighty":-5.788545,"marketCap":607126363},{"date":"2024-09-27","current":-8.806184,"twenty":-8.638371,"median":-6.616182,"eighty":-5.792924,"marketCap":611800796},{"date":"2024-10-04","current":-8.897214,"twenty":-8.745233,"median":-7.269437,"eighty":-5.800953,"marketCap":618125029},{"date":"2024-10-11","current":-9.340491,"twenty":-8.850511,"median":-7.455552,"eighty":-5.81701,"marketCap":648921294},{"date":"2024-10-18","current":-10.417023,"twenty":-8.905129,"median":-7.492045,"eighty":-5.857882,"marketCap":723712222},{"date":"2024-10-25","current":-9.902504,"twenty":-9.0017,"median":-7.670862,"eighty":-5.904593,"marketCap":687966558},{"date":"2024-10-31","current":-10.939457,"twenty":-9.257377,"median":-7.718702,"eighty":-5.904593,"marketCap":760007820},{"date":"2024-11-08","current":-14.709443,"twenty":-9.419648,"median":-7.959158,"eighty":-5.955683,"marketCap":894466512},{"date":"2024-11-15","current":-15.344855,"twenty":-9.514636,"median":-8.00261,"eighty":-5.970448,"marketCap":933105265},{"date":"2024-11-22","current":-15.521232,"twenty":-9.76398,"median":-8.132103,"eighty":-5.988527,"marketCap":943830613},{"date":"2024-11-29","current":-16.100113,"twenty":-9.924668,"median":-8.17293,"eighty":-5.994366,"marketCap":979031755},{"date":"2024-12-06","current":-16.33076,"twenty":-10.388526,"median":-8.285117,"eighty":-6.004584,"marketCap":993057210},{"date":"2024-12-13","current":-13.920266,"twenty":-10.815972,"median":-8.351032,"eighty":-6.018452,"marketCap":846477455},{"date":"2024-12-20","current":-13.694141,"twenty":-11.182468,"median":-8.50374,"eighty":-6.082845,"marketCap":832727009},{"date":"2024-12-27","current":-14.476534,"twenty":-12.093039,"median":-8.531114,"eighty":-6.098214,"marketCap":880303552},{"date":"2025-01-03","current":-12.794163,"twenty":-13.449021,"median":-8.618187,"eighty":-6.102358,"marketCap":778000234},{"date":"2025-01-10","current":-11.912274,"twenty":-13.190334,"median":-8.707238,"eighty":-6.108649,"marketCap":724373495},{"date":"2025-01-17","current":-10.130408,"twenty":-13.019383,"median":-8.746816,"eighty":-6.115785,"marketCap":616019980},{"date":"2025-01-24","current":-11.197719,"twenty":-12.871045,"median":-8.79431,"eighty":-6.143105,"marketCap":680922085},{"date":"2025-01-31","current":-11.523339,"twenty":-12.794163,"median":-8.877425,"eighty":-6.150011,"marketCap":700722728},{"date":"2025-02-07","current":-12.070562,"twenty":-12.328345,"median":-8.905129,"eighty":-6.232886,"marketCap":733998807},{"date":"2025-02-14","current":-11.432889,"twenty":-12.292165,"median":-8.964497,"eighty":-6.236339,"marketCap":695222549},{"date":"2025-02-21","current":-11.279124,"twenty":-12.151063,"median":-8.998138,"eighty":-6.308164,"marketCap":685872246},{"date":"2025-02-28","current":-9.62841,"twenty":-12.079607,"median":-9.059485,"eighty":-6.342695,"marketCap":585493990},{"date":"2025-03-07","current":-10.297741,"twenty":-11.943932,"median":-9.320702,"eighty":-6.355126,"marketCap":626195310},{"date":"2025-03-14","current":-11.193196,"twenty":-11.879712,"median":-9.419648,"eighty":-6.365485,"marketCap":680647077},{"date":"2025-03-21","current":-14.554795,"twenty":-11.943932,"median":-9.482973,"eighty":-6.379634,"marketCap":724377586},{"date":"2025-03-28","current":-14.68208,"twenty":-12.421509,"median":-9.574004,"eighty":-6.398202,"marketCap":730712447},{"date":"2025-04-04","current":-12.728528,"twenty":-13.089934,"median":-9.668992,"eighty":-6.415901,"marketCap":633486102},{"date":"2025-04-11","current":-10.2603,"twenty":-12.90813,"median":-9.741473,"eighty":-6.42488,"marketCap":510644883},{"date":"2025-04-17","current":-12.761733,"twenty":-12.945214,"median":-9.779811,"eighty":-6.430405,"marketCap":635138674},{"date":"2025-04-25","current":-15.833323,"twenty":-13.271407,"median":-9.84549,"eighty":-6.435239,"marketCap":788008663},{"date":"2025-05-02","current":-15.982746,"twenty":-13.932929,"median":-9.940463,"eighty":-6.440764,"marketCap":795445305},{"date":"2025-05-09","current":-15.25222,"twenty":-14.136351,"median":-10.102399,"eighty":-6.452984,"marketCap":728141003},{"date":"2025-05-16","current":-16.118891,"twenty":-14.245886,"median":-10.138549,"eighty":-6.460191,"marketCap":769515850},{"date":"2025-05-23","current":-16.637714,"twenty":-14.356129,"median":-10.19625,"eighty":-6.460792,"marketCap":794284465},{"date":"2025-05-30","current":-17.410053,"twenty":-14.523491,"median":-10.236057,"eighty":-6.585104,"marketCap":831155927},{"date":"2025-06-06","current":-17.864023,"twenty":-14.65894,"median":-10.342966,"eighty":-6.96771,"marketCap":852828466},{"date":"2025-06-13","current":-17.439532,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"marketCap":832563235}],"updateTime":1749924446750}}}